The Mundipharma network of independent associated companies says European regulators have approved use of Pelmeg, a biosimilar of Amgen’s white blood cell booster Neulasta. - News - PharmaTimes
by Selina McKee
www.pharmatimes.com/news/eu_oks_mundipharmas_neulasta_biosimilar_1265039AstraZeneca has bumped up its stake in US biotech Moderna, which is pioneering the development of a new class of drugs made of messenger RNA, to nine percent. - News - PharmaTimes
by Selina McKee
www.pharmatimes.com/news/az_ups_stake_in_moderna_1095937AstraZeneca has bought rights to an experimental antisense therapy from Ionis Pharmaceuticals, in a deal that could be worth more than $300 million - News - PharmaTimes
by Selina McKee
www.pharmatimes.com/news/az_buys_ionis_nash_candidate_1231077AstraZeneca is considering making a move on US group Medivation in a deal that could be worth around $7 billion, according to media reports. - News - PharmaTimes
by Selina McKee
www.pharmatimes.com/news/astrazeneca_eyeing_up_medivation_1020475European regulators have accepted Sandoz’ marketing application for a biosimilar of Pfizer’s $9-billion-a-year anti-inflammatory Enbrel, the world’s fifth biggest selling drug. - News - PharmaTimes
by Selina McKee
www.pharmatimes.com/news/sandoz_files_enbrel_biosimilar_in_the_eu_972256Astellas’ experimental acute myeloid leukaemia drug gilteritinib has been awarded orphan drug designation by the European Commission. - News - PharmaTimes
by Selina McKee
www.pharmatimes.com/news/astellas_bags_orphan_drug_status_for_aml_drug_1218291Takeda says it has received unconditional clearance from the US Federal Trade Commission for the proposed acquisition of Shire. - News - PharmaTimes
by Selina McKee
www.pharmatimes.com/news/takeda_gets_us_nod_for_shire_buy_1243748Sanofi Pasteur and MSD have announced the end of their European vaccines joint venture so that their own “distinct growth strategies” can be pursued instead. - News - PharmaTimes
by Selina McKee
www.pharmatimes.com/news/sanofi,_msd_to_dismantle_vaccines_jv_1020306Men suffering from constipation in Europe can now get treatment with Shire’s Resolor after regulators issued another green light substantially expanding its reach. - News - PharmaTimes
by Selina McKee
www.pharmatimes.com/news/eu_approves_constipation_drugs_971469NHS Confederation chief executive Niall Dickson is warning that the NHS is “under intolerable strain”, after the latest performance data continue to show growing demand and missed targets. - News - PharmaTimes
by Selina McKee
www.pharmatimes.com/news/nhs_under_intolerable_strain_1244161
